137 related articles for article (PubMed ID: 2969151)
1. Use of [3H]trimetoquinol as a radioligand in human platelets: interaction with putative endoperoxide/thromboxane A2 receptor sites.
Ahn CH; Wallace LJ; Miller DD; Feller DR
Thromb Res; 1988 May; 50(3):387-99. PubMed ID: 2969151
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo.
Shin Y; Romstedt KJ; Doyle K; Harrold MW; Gerhardt MA; Miller DD; Patil PN; Feller DR
Chirality; 1991; 3(2):112-7. PubMed ID: 1830752
[TBL] [Abstract][Full Text] [Related]
4. Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta.
Romstedt KJ; Shin Y; Shams G; Doyle K; Tantishaiyakul V; Clark MT; Adejare A; Hamada A; Miller DD; Feller DR
Biochem Pharmacol; 1993 Dec; 46(11):2051-9. PubMed ID: 8267653
[TBL] [Abstract][Full Text] [Related]
5. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells.
Shin Y; Romstedt KJ; Miller DD; Feller DR
J Pharmacol Exp Ther; 1993 Dec; 267(3):1017-23. PubMed ID: 7903383
[TBL] [Abstract][Full Text] [Related]
6. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses.
Huzoor-Akbar ; Mukhopadhyay A; Anderson KS; Navran SS; Romstedt K; Miller DD; Feller DR
Biochem Pharmacol; 1985 Mar; 34(5):641-7. PubMed ID: 3156599
[TBL] [Abstract][Full Text] [Related]
8. Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes.
Hung SC; Ghali NI; Venton DL; Le Breton GC
Biochim Biophys Acta; 1983 Feb; 728(2):171-8. PubMed ID: 6219702
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues.
Shams G; Romstedt KJ; Gerhardt MA; Harrold MW; Miller DD; Feller DR
Eur J Pharmacol; 1990 Aug; 184(1):21-31. PubMed ID: 1976530
[TBL] [Abstract][Full Text] [Related]
10. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.
Parent CA; Lagarde M; Venton DL; Le Breton GC
J Biol Chem; 1992 Apr; 267(10):6541-7. PubMed ID: 1532390
[TBL] [Abstract][Full Text] [Related]
11. 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets.
Fonlupt P; Croset M; Lagarde M
Thromb Res; 1991 Jul; 63(2):239-48. PubMed ID: 1837628
[TBL] [Abstract][Full Text] [Related]
12. A photoaffinity label for the thromboxane A2/prostaglandin H2 receptor in human blood platelets.
Kattelman EJ; Arora SK; Lim CT; Venton DL; Le Breton GC
FEBS Lett; 1987 Mar; 213(1):179-83. PubMed ID: 2951273
[TBL] [Abstract][Full Text] [Related]
13. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and platelet antiaggregatory activity of trimetoquinol analogs as endoperoxide/thromboxane A2 antagonists.
Harrold MW; Gerhardt MA; Romstedt K; Feller DR; Miller DD
Drug Des Deliv; 1987 Feb; 1(3):193-207. PubMed ID: 3509333
[TBL] [Abstract][Full Text] [Related]
15. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes.
Theis JG; Dellweg H; Perzborn E; Gross R
Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane antagonist properties of N-substituted trimetoquinol analogues.
Fedyna JS; Adejare A; Miller DD; Feller DR
Eur J Pharmacol; 1987 Mar; 135(2):161-71. PubMed ID: 2884118
[TBL] [Abstract][Full Text] [Related]
18. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
19. Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets.
Liel N; Mais DE; Halushka PV
Prostaglandins; 1987 Jun; 33(6):789-97. PubMed ID: 2959986
[TBL] [Abstract][Full Text] [Related]
20. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
